2012
DOI: 10.1016/s0140-6736(11)61780-7
|View full text |Cite
|
Sign up to set email alerts
|

Increasing incidence of serious infectious diseases and inequalities in New Zealand: a national epidemiological study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

15
196
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 205 publications
(213 citation statements)
references
References 22 publications
15
196
2
Order By: Relevance
“…Other research in NZ has found similar disparities for influenza hospitalisation and mortality [3]. Māori and Pacific people experience higher rates of hospitalisation for serious infectious diseases generally as well as respiratory illness (including influenza) in particular [3,17,23].…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…Other research in NZ has found similar disparities for influenza hospitalisation and mortality [3]. Māori and Pacific people experience higher rates of hospitalisation for serious infectious diseases generally as well as respiratory illness (including influenza) in particular [3,17,23].…”
Section: Discussionmentioning
confidence: 72%
“…In New Zealand, respiratory infections (including influenza) are the largest component of infectious disease hospitalisations, accounting for 38.5% of acute infectious disease hospitalisations and 9.5% of all acute admissions over the 1989-2008 period [3]. Although influenza is a common respiratory infection, it is not systemically tested for when patients are hospitalised, even for respiratory illnesses.…”
mentioning
confidence: 99%
“…Inequalities in infectious diseases associated with inadequate housing, for example, are substantial [20,21]. There are also inequities in access to health services (family doctor visits, prescription medicine) [22].…”
Section: Equity Challenges For Health Policymentioning
confidence: 99%
“…the interpretation of the many review mechanisms or the wide definition of new biologic medicines and associated ''market exclusivity'' [25][26][27]. New Zealand already has substantial inequity in access to pharmaceuticals and, without additional policy changes, increasing cost will only exacerbate this [20,28,29].…”
Section: Increasing Cost Of Policies Under the Trans-pacific Partnersmentioning
confidence: 99%
“…Several recent studies assessed the rate of infectious diseases in various countries (6)(7)(8). In addition, some studies were performed to evaluate the rate of some infectious diseases in Iran.…”
Section: Introductionmentioning
confidence: 99%